Vilon

Vilon is the shortest bioactive peptide (Lys-Glu, just 2 amino acids) that acts as a potent chromatin regulator, inducing heterochromatin unrolling and activating previously silenced genes related to immune function, cardiovascular health, gastrointestinal integrity, and tumor suppression—effectively “turning on” genes that aging has silenced without activating abnormal genetic programs. Research demonstrates that Vilon induces chromatin deheterochromatinization with simultaneous activation of synthetic processes through ribosomal gene reactivation.

Route

Subcutaneous injection

Dose range

67 mcg – 667 mcg

Frequency

Once per day (subcutaneous) for 5 consecutive days per cycle

Cycle length

Short 5-day pulses, often repeated every 3–6 months

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

Vilon is the shortest bioactive peptide (Lys-Glu, just 2 amino acids) that acts as a potent chromatin regulator, inducing heterochromatin unrolling and activating previously silenced genes related to immune function, cardiovascular health, gastrointestinal integrity, and tumor suppression—effectively “turning on” genes that aging has silenced without activating abnormal genetic programs. Research demonstrates that Vilon induces chromatin deheterochromatinization with simultaneous activation of synthetic processes through ribosomal gene reactivation.

Immune system benefits include enhanced T-cell and splenocyte activation through IL-2 signaling while simultaneously preventing autoimmune overreaction—unique balanced immune restoration. Cardiovascular effects involve 144-gene expression changes (combined with Epithalon) supporting hemodynamic function and vascular integrity. GI tract benefits include enhanced enzyme activity, improved barrier function reducing leaky gut, and optimized glucose/glycine absorption in aging. Tumor-suppression benefits involve reduced spontaneous tumor incidence through enhanced immune surveillance. For aging individuals seeking comprehensive gene expression restoration across immune, cardiovascular, and GI systems, Vilon offers unique ultra-short-peptide epigenetic modulation with profound multi-system effects.

Studied benefits

  • Studied for its role in immune system modulation and inflammation control
  • Early animal research suggests it may inhibit certain tumor growths and potentially extend lifespan, though human data is still very limited

Reported side effects

  • Appears well-tolerated in preclinical settings with only minor, localized skin reactions at the injection site reported

Protocol

Dosing Schedule (Subcutaneous)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

Crystagen (20mg)

Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~6.67 mg/mL).

Support immune system modulation and cellular regulation through bioregulatory peptide signaling.

Vilon (20mg)

Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~6.67 mg/mL).

Support immune modulation and thymic function markers through short-chain peptide bioregulation.

Phase / CycleDaily Dose (mcg)Draw at 6.67 mg/mLLog
Cycle 1, Day 167 mcg (0.067 mg)1 units (0.01 mL)+ Log
Cycle 1, Day 3200 mcg (0.20 mg)3 units (0.03 mL)+ Log
Cycle 1, Day 5333 mcg (0.33 mg)5 units (0.05 mL)+ Log
Cycle 2+ (Days 1–5)333–667 mcg10 units (0.1 mL)+ Log

Frequency

Once per day (subcutaneous) for 5 consecutive days per cycle.

Timing

Consistent time during the 5-day pulse; rotate sites.

Cycle length

Short 5-day pulses, often repeated every 3–6 months.

Unit calculator

Set your vial and water; the table above updates.

Open the full calculator →
Concentration

6.67 mg/mL

298 doses of 67 mcg per vial

Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.

Context

Lifestyle considerations

Follow a nutrient-dense, balanced diet rich in protein and micronutrients to support the bioregulator's role in maintaining the functional health of the immune system and thymus. Stay physically active to promote systemic circulation, facilitating the delivery of this dipeptide to target tissues for cellular repair. Ensure 7–9 hours of quality sleep to align with the body's natural circadian rhythm for immune surveillance and regeneration. Practice consistent stress management, as high cortisol levels can lead to premature thymic involution and counteract the peptide’s potential for promoting cellular longevity.

Evidence

Research summaries

Vilon Helping Elderly Cancer Patients Live Longer

Findings: Boosts survival after tough cancer treatments, cuts complications like infections, and improves daily life quality for older folks with gut cancers.

Doctors gave Vilon to old patients getting surgery, radiation, and chemo for rectal or colon cancer. Those getting it had way better 2-year survival, fewer repeat tumors, less spread, and quicker bounce-back. No big side effects. It's like giving the body extra strength to heal and fight after hard hits. Quality of life went up—they felt stronger, less tired. This shows Vilon as a helper drug for cancer care in seniors where normal treatments wear them out.

Read the study ↗

Vilon Fixing Kidney Problems Early On

Findings: Lowers bad proteins in blood that harm kidneys and fixes leaky small blood tubes, helping early chronic kidney disease stay under control.

Rats with starting kidney failure got Vilon shots. Two months in, their blood had less transforming growth factor (a troublemaker making scars), and gut blood vessels stopped leaking fluids. This kept kidneys working better longer. By months 4-6, effects faded, so best early. Vilon balances body fluids and stops damage spread, like patching leaks before flood. Promising for human kidney protection without strong meds.

Read the study ↗

Vilon Slowing Bladder Cancer Growth in Animals

Findings: Cuts new cancer starts by half, lowers pre-cancer spots, great for preventing urinary tract tumors.

Rats fed cancer-causing stuff got Vilon. Only 56% grew bladder tumors vs 75% without. Early bad changes dropped a lot too. Vilon stopped cancer from taking hold by tweaking cell growth signals. Twice less serious tumors formed. This hints it's a blocker for chemicals turning normal cells wild. Safe in tests, could pair with checkups for high-risk people. Like a shield for bladder lining.

Read the study ↗

Vilon Boosting Cell Youth and Fighting Tumors

Findings: Kills more tumor cells, slows growth via better cell death, helps old rats fight transplanted cancers.

Old rats with planted sarcoma tumors got tiny Vilon doses. Tumor cells died more (apoptosis up), growth slowed, some tumors got bloody and shrank. Vilon changed blood vessel growth around tumors, starving them. Better than controls. Also, another peptide Epithalamin did similar. Shows Vilon tweaks tumor neighborhood to fight back. Hope for cancer add-on therapy, especially in aging bodies where immunity dips. Vilon research focuses on anti-aging and immune perks, strong in animal and small human tests from Russian labs. It nudges genes for repair, fights inflammation, protects organs. Not FDA-approved yet—research only. Benefits shine for longevity, cancer aid, kidney health.

Read the study ↗
More references (3)

Identification

Chemistry

cas
45234-02-4
formula
C₁₁H₂₁N₃O₅
molecular weight
275.3 Da (or 275.3 g/mol)
sequence
-
source
Synthetic; derived from or modeled after natural thymic peptide sequences
biosynthesis
Chemically synthesized dipeptide; nonribosomal origin
type
Linear dipeptide with standard peptide bond connecting lysine and glutamic acid residues

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor